Instant Kit Synthesis of 62Cu Radiopharmaceuticals
62Cu 放射性药物的即时试剂盒合成
基本信息
- 批准号:7257798
- 负责人:
- 金额:$ 77.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBusinessesCancer PatientChemistryClinicalClinical ResearchCommunitiesCompatibleCountCoupledCyclotronsDailyDevelopmentDiagnosisDiagnosticDiagnostic ImagingDiagnostic Neoplasm StagingDoseDrug FormulationsFeasibility StudiesFluorineFutureHalf-LifeHarvestHumanHypoxiaImageImaging TechniquesInvasiveIsotonic ExerciseLabelLettersMapsMeasurementMeasuresMechanicsMetabolismMethodsModalityMyocardial perfusionOrganPerfusionPharmaceutical PreparationsPharmacy facilityPhasePositron-Emission TomographyPreparationProductionPuncture procedureRadiopharmaceuticalsRangeRattusResearch InfrastructureRestSolutionsSterilityStressSyringesSystemTechniquesTechnologyTestingThiosemicarbazonesTracerUnited States Food and Drug AdministrationUniversitiesVial deviceWisconsinbasecopper (II) diacetyl-di(N(4)-methylthiosemicarbazone)costdesigndosimetryinnovationmalignant breast neoplasmminiaturizenew technologyoncologypreventprototypesizesuccesstumor
项目摘要
DESCRIPTION (provided by applicant):
Positron Emission Tomography (PET) is a rapidly emerging non-invasive imaging technique with the exceptional ability to provide quantitative functional information. Unfortunately, this modality is currently limited to a single approved radiopharmaceutical agent, 18F-FDG, which measures tumor metabolism. The potential of PET in oncology can be advanced substantially by development of PET tracers that can assess other useful clinical parameters, such as the quantitative measurement of tumor perfusion and hypoxia. Such information is extremely useful for diagnosis and staging of cancer. We propose to develop a micro 62Znfl2Cu generator to produce the 9.7 minute 62Cu PET tracer at very high isotonic concentration and further to develop kit formulations to provide instant synthesis of 62 Cu-bis(thiosemicarbazone) compounds. Phase I will concentrate on demonstrating the feasibility of the combined microgenerator and instant kits for the two perfusion tracers approximately Cu-PTSM and x2CU-ETS, and the hypoxia tracer 62 Cu-ATSM. In Phase II, the microgenerator and kit formulations will be fully developed for human use, INDs will be submitted to the FDA for the three compounds, and finally, limited clinical feasibility studies focusing on serial perfusion and hypoxia imaging completed in a brief imaging session will be performed. The resulting perfusion normalized hypoxia map is expected to produce a highly superior measure of regional tumor hypoxia and thus superior information to guide treatment. The distributable generator produced tracers, together with the widely expanding availability of PET, can have far-reaching benefits in cancer patient treatment and management.
描述(由申请人提供):
正电子发射断层扫描(PET)是一种快速发展的非侵入性成像技术,具有提供定量功能信息的卓越能力。不幸的是,这种方式目前仅限于单一批准的放射性药物18F-FDG,其测量肿瘤代谢。PET在肿瘤学中的潜力可以通过开发PET示踪剂来大大提高,PET示踪剂可以评估其他有用的临床参数,例如肿瘤灌注和缺氧的定量测量。这些信息对于癌症的诊断和分期非常有用。我们建议开发微型62 Znf 12 Cu发生器以在非常高的等渗浓度下产生9.7分钟的62 Cu PET示踪剂,并进一步开发试剂盒制剂以提供62 Cu-双(缩氨基硫脲)化合物的即时合成。第一阶段将集中于证明组合的微型发生器和即时试剂盒用于两种灌注示踪剂(大约Cu-PTSM和x2 CU-ETS)和缺氧示踪剂62 Cu-ATSM的可行性。在第二阶段,微型发电机和试剂盒配方将完全开发用于人类使用,IND将提交给FDA的三种化合物,最后,有限的临床可行性研究,重点是在简短的成像会议中完成的连续灌注和缺氧成像。期望得到的灌注标准化缺氧图产生高度上级的局部肿瘤缺氧测量,从而产生指导治疗的上级信息。可分配的发生器产生的示踪剂,加上PET的广泛扩展的可用性,可以在癌症患者的治疗和管理中产生深远的好处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY L LACY其他文献
JEFFREY L LACY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY L LACY', 18)}}的其他基金
Receptor-Targeted Neuroendocrine Tumor Imaging with Generator-Produced Cu-62
使用发生器产生的 Cu-62 进行受体靶向神经内分泌肿瘤成像
- 批准号:
9200463 - 财政年份:2016
- 资助金额:
$ 77.06万 - 项目类别:
Novel small animal PET scanner using 2.0 mm lead-walled straw detectors
使用 2.0 毫米铅壁吸管探测器的新型小动物 PET 扫描仪
- 批准号:
7326740 - 财政年份:2007
- 资助金额:
$ 77.06万 - 项目类别:
Straw Detector Positron Emission Mammography System
吸管探测器正电子发射乳腺X线摄影系统
- 批准号:
7055405 - 财政年份:2006
- 资助金额:
$ 77.06万 - 项目类别:
Straw Detector Positron Emission Mammography System
吸管探测器正电子发射乳腺X线摄影系统
- 批准号:
7495552 - 财政年份:2006
- 资助金额:
$ 77.06万 - 项目类别:
IMPROVED PRODUCTION OF 62ZN FOR PET IMAGING WITH 62CU
使用 62CU 改进用于 PET 成像的 62ZN 的生产
- 批准号:
7541852 - 财政年份:2006
- 资助金额:
$ 77.06万 - 项目类别:
Straw Detector Positron Emission Mammography System
吸管探测器正电子发射乳腺X线摄影系统
- 批准号:
7490761 - 财政年份:2006
- 资助金额:
$ 77.06万 - 项目类别:
Straw Detector Positron Emission Mammography System
吸管探测器正电子发射乳腺X线摄影系统
- 批准号:
7586620 - 财政年份:2006
- 资助金额:
$ 77.06万 - 项目类别:
Instant Kit Synthesis of 62Cu Radiopharmaceuticals
62Cu 放射性药物的即时试剂盒合成
- 批准号:
7106484 - 财政年份:2004
- 资助金额:
$ 77.06万 - 项目类别:
Instant Kit Synthesis of 62Cu Radiopharmaceuticals
62Cu 放射性药物的即时试剂盒合成
- 批准号:
7090274 - 财政年份:2004
- 资助金额:
$ 77.06万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 77.06万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 77.06万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 77.06万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 77.06万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 77.06万 - 项目类别:
Training Grant